Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Morgan Stanley Maintains Equal-Weight on The RealReal, Lowers Price Target to $17

Morgan Stanley maintains The RealReal (NASDAQ:REAL) with a Equal-Weight and lowers the price target from $18 to $17.
byBenzinga Newsdesk
February 24, 2022
1 minute read
Total
0
Shares
0
0
0
0
0
0

Morgan Stanley maintains The RealReal (NASDAQ:REAL) with a Equal-Weight and lowers the price target from $18 to $17.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts
Read More

Aeglea BioTherapeutics Announces Achievement Of Primary Endpoint In Phase 3 Study Of Pegzilarginase In Patients With Arginase 1 Deficiency; Co. Reports ‘80% plasma arginine reduction (primary endpoint; p<0.0001) accompanied by a positive trend in GMFM-…

By Benzinga Newsdesk
Today, 11:37 PM
80% plasma arginine reduction (primary endpoint; p < 0.0001) accompanied by a positive trend in GMFM-E, a key clinical assessment of patient mobility 90.5% of patients achieved normal plasma arginine

AGLE